BSE filing, NSE: TEJASNET. Summary written from the filing by ALFA Finder's alert engine.
Tejas Networks Ltd: key numbers
- Share price
- ₹412.00
- Market cap
- ₹7,339 Cr
- Revenue (annual)
- ₹1,103 Cr
- Net profit (annual)
- ₹-908.9 Cr
- P/E (TTM)
- -9.0×Sector 58.5×
- Promoter holding
- 53.28%-0.05% QoQ
- FII holding
- 6.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejas Networks Ltd
All →Tejas Networks Credit Rating
ICRA reaffirmed Tejas Networks' [ICRA]A+(Stable) long-term rating and [ICRA]A1+ short-term rating. The rating covers Rs.6,000 Crore of credit facilities and a Rs.500 Crore CP programme.
Tejas Networks Earnings Call Transcript: Key Takeaways
Tejas reported Q2 FY27 revenue of INR 406 Cr, up 55% YoY, though it posted a PAT loss of INR 207 Cr. Focus remains on BSNL 4G order execution and wireless expansion.
Tejas Networks Other Announcement
Tejas Networks Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Tejas Networks Investor Presentation: Key Takeaways
Tejas reported Q2FY27 revenue of ₹406 Cr, up 55% YoY, but posted a ₹207 Cr net loss. Strategy focuses on BSNL 4G execution and international expansion.
Tejas Networks Results Update
Tejas Networks reported Q2 FY27 financial results, with net revenue of Rs. 406 Crore. The company also highlighted strong demand for its telecom and networking products.
Tejas Networks Q2 FY27 Results: Net Loss of ₹206.9 Cr, Loss Narrows
Tejas Networks Ltd reported revenue from operations of ₹405.7 Cr (+55.0% YoY) and a net loss of ₹206.9 Cr for Q2 FY27.
- Key figure
- Net loss ₹206.9 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.